04 October 2016
Maintaining cell identity: PRC2-mediated regulation of transcription and cancer
Comet, Itys, Eva M. Riising, Benjamin Leblanc & Kristian Helin (2016). Maintaining cell identity: PRC2-mediated regulation of transcription and cancer. Nat Reviews Cancer, 1-8, doi:10.1038/nrc.2016.83.
Enhancer of zeste homologue 2 (EZH2), the catalytic subunit of Polycomb repressive complex 2 (PRC2), has attracted broad research attention in the past few years because of its involvement in the development and maintenance of many types of cancer and the use of specific EZH2 inhibitors in clinical trials. Several observations show that PRC2 can have both oncogenic and tumour-suppressive functions. We propose that these apparently opposing roles of PRC2 in cancer are a consequence of the molecular function of the complex in maintaining, rather than specifying, the transcriptional repression state of its several thousand target genes.